New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
Authors:
- Erika LarreaELErika Larrea
- Carla SoleCSCarla Sole
- Lorea ManterolaLMLorea Manterola
- Ibai GoicoecheaIGIbai Goicoechea
- María ArmestoMAMaría Armesto
- María ArestinMAMaría Arestin
- María M. CaffarelMCMaría M. Caffarel
- Angela M. AraujoAAAngela M. Araujo
- María AraizMAMaría Araiz
- Marta Fernandez-MercadoMFMarta Fernandez-Mercado
- Charles H. LawrieCLCharles H. Lawrie
Open Access
- 27 April 2016
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 17 (5) , 627
Abstract
The effective and efficient management of cancer patients relies upon early diagnosis and/or the monitoring of treatment, something that is often difficult to achieve using standard tissue biopsy techniques. Biological fluids such as blood hold great possibilities as a source of non-invasive cancer biomarkers that can act as surrogate markers to biopsy-based sampling. The non-invasive nature of these “liquid biopsies” ultimately means that cancer detection may be earlier and that the ability to monitor disease progression and/or treatment response represents a paradigm shift in the treatment of cancer patients. Below, we review one of the most promising classes of circulating cancer biomarkers: microRNAs (miRNAs). In particular, we will consider their history, the controversy surrounding their origin and biology, and, most importantly, the hurdles that remain to be overcome if they are really to become part of future clinical practice.Keywords
This publication has 461 references indexed in Scilit:
- Extracellular MicroRNAs in Urologic Malignancies: Chances and ChallengesInternational Journal of Molecular Sciences, 2013
- BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplificationMolecular Cancer, 2013
- Plasma Processing Conditions Substantially Influence Circulating microRNA Biomarker LevelsPLOS ONE, 2013
- Salivary MicroRNAs as Promising Biomarkers for Detection of Esophageal CancerPLOS ONE, 2013
- Role of Notch signaling pathway in gastric cancer pathogenesisContemporary Oncology, 2013
- miR‐10b*, a master inhibitor of the cell cycle, is down‐regulated in human breast tumoursEMBO Molecular Medicine, 2012
- MicroRNA-210 targets antiapoptotic Bcl-2 expression and mediates hypoxia-induced apoptosis of neuroblastoma cellsArchives of Toxicology, 2012
- Differential expression of miRNAs in the serum of patients with high‐risk oral lesionsCancer Medicine, 2012
- Circulating micro‐RNA expression profiles in early stage nonsmall cell lung cancerInternational Journal of Cancer, 2011
- Microrna expression distinguishes between germinal center B cell‐like and activated B cell‐like subtypes of diffuse large B cell lymphomaInternational Journal of Cancer, 2007